Stefan König став новим генеральним директором групи OPTIMA

The participation will allow specialists of the leading national pharmaceutical manufacturer to improve the competencies necessary for the production of drugs based on RNA technology. The project is implemented within…

Cytotoxics and cytostatics are in increased demand in the global pharmaceutical market. To meet this steadily increasing demand, Aenova, a leading development service provider and contract manufacturer for the pharmaceutical and…